Prevention of Second Primary Tumors by an Acyclic Retinoid in Patients with Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Prevention of Second Primary Tumors by an Acyclic Retinoid in Patients with Hepatocellular Carcinoma

Published:2005 Issue:1 Volume:48 Page:39-45
ISSN:1423-0100
Container-title:Intervirology
language:en
Short-container-title:Intervirology

Author:

Takai Koji,Okuno Masataka,Yasuda Ichiro,Matsushima-Nishiwaki Rie,Uematsu Takahiro,Tsurumi Hisashi,Shiratori Yoshimune,Muto Yasutoshi,Moriwaki Hisataka

Publisher

S. Karger AG

Subject

Infectious Diseases,Virology

Reference21 articles.

1. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy

2. Positive and negative regulations of albumin gene expression by retinoids in human hepatoma cell lines

3. Retinoid Agonist Activities of Synthetic Geranyl Geranoic Acid Derivatives

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future;Hepatology Communications;2024-06

2. Retinoids in cancer chemoprevention and therapy: Meta-analysis of randomized controlled trials;Frontiers in Genetics;2022-11-09

3. Adjuvant treatment strategy after curative resection for hepatocellular carcinoma;Frontiers of Medicine;2021-03-23

4. Updates and advancements in the management of hepatocellular carcinoma patients after hepatectomy;Expert Review of Gastroenterology & Hepatology;2019-10-30

5. Acyclic Retinoid Combined With Tenascin-C-derived Peptide Reduces the Malignant Phenotype of Neuroblastoma Cells Through N-Myc Degradation;Anticancer Research;2019-07